Synergy effect of the appetite hormone GLP-1 (LiragluTide) and Exercise on maintenance of weight loss and health after a low calorie diet - the S-LiTE randomized trial
Latest Information Update: 02 Nov 2023
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms S-LiTE
- 06 Oct 2023 Results assessing to investigate changes in bone health during a diet-induced weight loss followed by a one-year weight maintenance intervention with liraglutide, exercise, or the combination of both compared with a placebo group presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
- 06 Oct 2023 Results assessing LEAP2 levels after diet-induced weight loss and following one year of treatment with exercise, the GLP-1 receptor agonist liraglutide, or a combination of exercise and liraglutide presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
- 30 Jun 2022 Results of sub-study of this study assessing long-term effects of weight loss on semen parameters in 56 men, published in the Human Reproduction.